Barr E S & CO Abbott Laboratories Transaction History

Barr E S & CO

$1.65 Billion
Q4 2024

A detailed history of Barr E S & CO transactions in Abbott Laboratories stock. As of the latest transaction made, Barr E S & CO holds 2,655 shares of ABT stock, worth $365,620. This represents 0.02% of its overall portfolio holdings.

Number of Shares

2,655

Previous 2,675 0.75%

Holding current value

$365,620

Previous $304,000 1.32%

% of portfolio

0.02%

Previous 0.02%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	SELL	$111.93 - $119.39 $2,238 - $2,387	-20 Reduced 0.75%	2,655 $300,000
Q3 2024 Nov 14, 2024	SELL	$100.07 - $118.13 $6,304 - $7,442	-63 Reduced 2.3%	2,675 $304,000
Q1 2024 May 15, 2024	SELL	$109.52 - $120.96 $239,958 - $265,023	-2,191 Reduced 44.45%	2,738 $311,000
Q4 2023 Feb 09, 2024	SELL	$90.19 - $110.4 $9,019 - $11,040	-100 Reduced 1.99%	4,929 $542,000
Q3 2023 Nov 14, 2023	SELL	$95.53 - $114.62 $13,756 - $16,505	-144 Reduced 2.78%	5,029 $487,000
Q2 2023 Aug 10, 2023	BUY	$100.78 - $112.29 $38,699 - $43,119	384 Added 8.02%	5,173 $563,000
Q3 2022 Nov 14, 2022	SELL	$96.76 - $112.03 $9,676 - $11,203	-100 Reduced 2.05%	4,789 $463,000
Q2 2022 Aug 15, 2022	SELL	$102.07 - $123.37 $51,035 - $61,685	-500 Reduced 9.28%	4,889 $531,000
Q4 2021 Feb 14, 2022	BUY	$115.53 - $141.46 $72,783 - $89,119	630 Added 13.24%	5,389 $758,000
Q3 2021 Nov 10, 2021	BUY	$116.66 - $129.06 $3,849 - $4,258	33 Added 0.7%	4,759 $562,000
Q2 2021 Aug 13, 2021	BUY	$105.79 - $124.53 $1,057 - $1,245	10 Added 0.21%	4,726 $548,000
Q4 2020 Feb 16, 2021	BUY	$105.0 - $114.42 $52,500 - $57,210	500 Added 11.86%	4,716 $516,000
Q2 2020 Aug 14, 2020	SELL	$76.57 - $98.0 $22,970 - $29,400	-300 Reduced 6.64%	4,216 $385,000
Q1 2020 May 15, 2020	SELL	$62.82 - $91.86 $55,470 - $81,112	-883 Reduced 16.35%	4,516 $356,000
Q2 2019 Aug 08, 2019	SELL	$72.88 - $85.0 $45,550 - $53,125	-625 Reduced 10.38%	5,399 $454,000
Q1 2019 May 15, 2019	BUY	$66.22 - $80.06 $31,454 - $38,028	475 Added 8.56%	6,024 $482,000
Q4 2018 Feb 14, 2019	SELL	$65.56 - $74.27 $91,521 - $103,680	-1,396 Reduced 20.1%	5,549 $401,000
Q3 2018 Nov 07, 2018	SELL	$60.81 - $73.36 $18,243 - $22,008	-300 Reduced 4.14%	6,945 $509,000
Q2 2018 Aug 10, 2018	SELL	$57.57 - $63.54 $4,778 - $5,273	-83 Reduced 1.13%	7,245 $442,000
Q1 2018 May 15, 2018	BUY	$56.27 - $63.62 $21,663 - $24,493	385 Added 5.55%	7,328 $439,000
Q4 2017 Feb 14, 2018	BUY	$53.68 - $57.47 $32,744 - $35,056	610 Added 9.63%	6,943 $396,000
Q3 2017 Nov 09, 2017	BUY	$48.06 - $53.64 $304,363 - $339,702	6,333	6,333 $338,000

Others Institutions Holding ABT

# of Institutions

3,370

Shares Held

1.36B

Call Options Held

10.6M

Put Options Held

8.73M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $241B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barr E S & CO, based on Form 13F filings with the SEC.

News

Stay updated on Barr E S & CO with notifications on news.

Account